Workflow
鲁抗医药(600789.SH)拟竞购和成公司股权 进一步优化资源配置
LKPCLKPC(SH:600789) 智通财经网·2025-09-19 07:44

Core Viewpoint - Lu Kang Pharmaceutical (600789.SH) announced its intention to acquire a 1.9231% stake in Hecheng Pharmaceutical Co., Ltd. from the Zoucheng Economic Development Zone Management Committee through a public bidding process, aiming to optimize resource allocation and improve operational decision-making efficiency [1] Group 1 - The joint venture between Lu Kang Pharmaceutical and the Zoucheng Economic Development Zone Management Committee is focused on the development of Hecheng Pharmaceutical Co., Ltd. [1] - The Zoucheng Economic Development Zone Management Committee plans to transfer its 1.9231% stake in Hecheng Pharmaceutical through the Shandong Property Rights Exchange Center [1] - Upon completion of the transaction, Lu Kang Pharmaceutical will directly hold 100% of Hecheng Pharmaceutical, with no changes to the consolidated financial reporting scope [1]